Press release
Global Peptide Therapeutics Market to Reach US$23.7 bn by 2020, Rising Prevalence of Cancer to Drive Growth
Browse the full Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Therapeutic peptides are naturally occurring short amino acid monomer chains, which are beneficial in the treatment of several kinds of cancer, respiratory disorders, cardiovascular disorders, central nervous system (CNS) disorders, blood-related disorders, and other chronic diseases. More than seven thousand organically occurring peptides have been identified till now. Insulin was the first peptide, to be therapeutically administered. Although being used for more than 50 years now, it still enjoys the reputation of the most commonly prescribed peptide.
The research report has studied the global peptide therapeutics market on the basis of application, the route of administration, marketing status, and its regional spread. Based on application, the market is classified into cancer, central nervous system disorders, cardiovascular disorders, gastrointestinal disorders, hematological disorders, respiratory disorders, infections, and acromegaly.
By the route of administration, the report has segmented the peptide therapeutics market into oral administration and parenteral administration and by marketing status, the market has been categorized as branded therapeutic peptides and generic therapeutic peptides.
On the regional front, the worldwide peptide therapeutics market has been classified into Europe, Asia Pacific, North America, and the Rest of the World. In 2014, North America and Europe collectively occupied a share of more than 60% in the overall market.
Asia Pacific, on the other hand, is emerging as the most promising market for peptide therapeutics across the world. Over the forecast period, analysts project Asia Pacific to register the fastest growth among all the regional markets for peptide therapeutics, states the research report.
Japan, China, and India lead the Asia Pacific peptide therapeutics market on account of large pool of patients suffering from cancer and other chronic ailments in these countries. The rapid development in economic condition and the rising awareness pertaining to the treatment of cancer and various other chronic diseases, using therapeutic peptides, are the other prominent factors anticipated to boost the peptide therapeutics market in Asia Pacific, notes the study.
Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Sanofi, Roche Holdings AG, PolyPeptide Group, Novo Nordisk A/S, Novartis AG, Merck & Co. Inc., Lonza Group Ltd., Ipsen S.A., Eli Lilly and Co., CordenPharma International GmbH, Bachem Holding AG, AstraZeneca Plc, and Amgen Inc. are some of the major companies operating in the global peptide therapeutics market, profiled in this report.
Download Exclusive Brochure of This Report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=418
The global peptide therapeutics market is segmented into:
By Application
By Application
Cancer
Zoladex (goserelin)
Velcade (bortezomib)
Lupron/ Enantone/ Eligard (leuprorelin)
Others
Cardiovascular
Angiomax (bivalirudin)
Integrilin (eptifibatide)
Central Nervous System
Copaxone (glatiramer)
Metabolic Disorders
Victoza (liraglutide)
Byetta (exenatide)
Others
Infection
Incivek (telaprevir)
Victrelis (boceprevir)
Hematological Disorders
Firazyr (icatibant)
Kalbitor (ecallantide)
Gastrointestinal Disorders
Gattex (teduglutide)
Linzess (linaclotide)
Respiratory Disorders
Acromegaly
Other Applications
By Route of Administration
Parenteral
Oral
By Marketing Status
Branded
Generic
By Region
North America
Europe
Asia Pacific
Rest of the World
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Therapeutics Market to Reach US$23.7 bn by 2020, Rising Prevalence of Cancer to Drive Growth here
News-ID: 453990 • Views: …
More Releases from Transparency Market Research - Pharmaceutical
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview
The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the…
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise…
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market:
Introduction
Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for…
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.
Overview
Radiofrequency ablation is a minimally invasive surgical…
More Releases for Peptide
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
There are two main types of products available in the customized peptide synthesis…
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected…
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,…
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.
Click to Request a Sample:…
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug…
